Lumpy skin disease vaccine developed by Bharat Biotech group firm with ICAR gets CDSCO licence

Daily Current Affairs / Lumpy skin disease vaccine developed by Bharat Biotech group firm with ICAR gets CDSCO licence

Change Language English Hindi

Category : Science and Tech Published on: February 17 2025

Share on facebook

Biovet, a Bharat Biotech group firm, received CDSCO approval for Biolumpivaxin, the world's first DIVA marker vaccine for lumpy skin disease (LSD) in cattle and buffaloes, developed in collaboration with ICAR.
This vaccine received approval from the Central Drugs Standard Control Organization (CDSCO) for commercial use.

Pakistan shuts airspace and halts trade with India post-Pahalgam attack.
Read More....
BHIM app introduces UPI Circle feature with partial delegation.
Read More....
Pakistan terms diversion of Indus waters as ‘act of war’, threatens Simla Agreement abeyance.
Read More....
Tamil Nadu bans raw egg-based mayonnaise for a year due to health risks.
Read More....
Sports certificates now available via DigiLocker: Launched by Union Minister Mandaviya.
Read More....
World Bank revises India’s 2025-26 GDP growth forecast to 6.3%.
Read More....
US imposes fresh sanctions on Iran’s energy sector amid nuclear talk uncertainty.
Read More....
Klaus Schwab resigns as WEF Chairman after five decades; interim chair appointed.
Read More....
UNESCO adds 16 new Global Geoparks, bringing total to 229 across 50 countries.
Read More....
World Immunization Week (April 24–30) promotes vaccine awareness to protect all age groups.
Read More....

Lumpy skin disease vaccine developed by Bharat Biotech group firm with ICAR gets CDSCO licence